ipratropium

(redirected from Atrovent HFA)
Also found in: Medical.
Related to Atrovent HFA: Symbicort, Ventolin HFA

ip·ra·tro·pi·um

 (ĭp′rə-trō′pē-əm)
n.
An inhalant bronchodilator drug, C20H30NO3, used in the form of its bromide to treat obstructive pulmonary disease.

[Shortening of isopropylnoratropinium : iso- + propyl + nor- + atropin(e) + -ium.]

ipratropium

(ˌaɪprəˈtrəʊpɪəm)
n
(Recreational Drugs) drugs an anticholinergic bronchodilator that is used esp in the treatment of certain forms of asthma
References in periodicals archive ?
Four doses of GP MDI were compared to placebo and Atrovent HFA Inhalation Aerosol, a short-acting muscarinic antagonist given four times a day (QID).
Atrovent HFA was recently approved but won't be available until later this year.
Special Considerations: Atrovent HFA is not indicated for initial treatment of acute bronchospasm where a rapid response is required.
Atrovent HFA is the latest inhalation aerosol approved by the Food and Drug Administration after reformulation without CFCs; others include fluticasone HFA (Flovent HFA Inhalation Aerosol, GlaxoSmithKline) and two formulations of albuterol sulfate HFA (Proventil HFA, 3M Pharmaceuticals; Ventolin HFA, GlaxoSmithKline).